IDEAYA Biosciences (IDYA) Long-Term Investments (2019 - 2026)

IDEAYA Biosciences (IDYA) has 8 years of Long-Term Investments data on file, last reported at $301.7 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 15.88% year-over-year to $301.7 million; the trailing twelve-month figure through Mar 2026 stood at $301.7 million (down 15.88% YoY), and the FY2025 full-year result was $410.3 million, up 1.1% from the prior year.
• Long-Term Investments fell to $301.7 million in Q1 2026, from $410.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $410.3 million in Q4 2025 to a low of $7.7 million in Q3 2022.
• A 5-year average of $192.1 million and a median of $242.6 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments plunged 93.66% in 2022 and jumped 1966.75% in 2024, its largest moves.
• Tracing IDYA's Long-Term Investments over 5 years: stood at $8.3 million in 2022, then jumped by 1192.44% to $107.5 million in 2023, then soared by 277.55% to $405.8 million in 2024, then climbed by 1.1% to $410.3 million in 2025, then retreated by 26.46% to $301.7 million in 2026.
• Business Quant data shows IDYA's Long-Term Investments at $301.7 million in Q1 2026, $410.3 million in Q4 2025, and $350.0 million in Q3 2025.